328 W. Claiborne St.
P.O. Box 964
Monroeville, Alabama 36460
(251) 575-4203
     
Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Medicaid Could Save $2.6 Billion a Year With Dip in SmokingFDA Halts All Sales of Pelvic Mesh Products Tied to Injuries in WomenAnother Cost of the Opioid Epidemic: Billions of Dollars in Lost TaxesHealth Tip: Using an AEDNurse Practitioners Often Restricted From Prescribing Opioid TreatmentsForested Counties Have Lower Medicare Costs, Study FindsSimple CPR Doubles Survival OddsUninsured Get Short Shrift on Hospital StaysSpecial Bag Helps Patients Get Rid of Unused OpioidsHealth Tip: Responsibilities of Non-VaccinationDo Doctors Hounded by Malpractice Claims Just Shift Their Practice Elsewhere?Bans on Texting While Behind the Wheel Making Roads SaferColorado Sees Spike in ER Visits After Pot Made LegalMajor Medical Groups Call for Soda TaxesCould the U.S. Mail Deliver Better Colon Cancer Screening Rates?Opioid Rxs Decreasing, But Not for All DoctorsAfter Chinese Infant Gene-Editing Scandal, U.S. Health Officials Join Call for a BanAre 'Inactive' Ingredients in Your Drugs Really So Harmless?Need to Be Vaccinated? Try Your Local PharmacyBystanders Key to Cutting Cardiac Arrest DeathsMany Black Americans Live in Trauma Care 'Deserts'FDA Issues Asbestos Warning About Some Claire's Cosmetic ProductsFDA to Crack Down on Retailers That Keep Selling Tobacco to KidsBlood Donation by Teen Girls May Raise Anemia RiskNurses' Long Hours, Moonlighting Could Pose Patient Safety RiskBerkeley's Efforts Suggest Soda Taxes Do Cut Soda SalesOpioid Overdose Deaths Quadruple, Centered in 8 StatesPayments for Research Can Lead to Lies: StudyFDA Aims to Strengthen Sunscreen RulesAre Primary Care Doctors Prepared to Discuss Cancer Treatment?FDA Fell Short in Preventing Fentanyl Abuse Crisis, Report ClaimsPrimary Care Doctors Help Boost Life Spans, But More Are NeededMore Car Crashes Tied to Drivers High on OpioidsPoor Whites Bear the Brunt of U.S. Opioid Crisis, Studies FindFDA to Tighten Oversight of SupplementsAs U.S. Measles Outbreaks Spread, Why Does 'Anti-Vax' Movement Persist?Even Brief EMS Delay Can Cost Lives After Car CrashHealth Tip: Know Your Family's Medical HistoryPatients With Primary Care Docs May Get Better Health CareBlood Donors Needed as Cold Weather Freezes U.S. SupplyAHA: Medical Experts 'Sound the Alarm' on Medical MisinformationWhite House Plan to Disclose Drug Prices May Not Drive Down Costs: StudyCan Artificial Intelligence Read X-Rays?Virtual Doctor Visits Get High Marks in New SurveyBig Pharma's Marketing to Docs Helped Trigger Opioid Crisis: StudyDisrupted Sleep Plagues Hospital Patients, But New Program Might HelpOpioid Prescriptions Almost Twice as Likely for Rural vs. Urban AmericansClimate Change Already Hurting Human Health, Review ShowsCalling All Blood Donors …Even Older Drugs Are Getting Steep Price Hikes, Study Finds
Links
Related Topics

Health Insurance
Healthcare

New Approach to Opioid Crisis: Supervised Heroin Injection Programs?

HealthDay News
by -- Robert Preidt
Updated: Dec 6th 2018

new article illustration

THURSDAY, Dec. 6, 2018 (HealthDay News) -- It's not standard practice in the United States, but supervised access to medical-grade heroin may reduce the risk of harm for heroin addicts unable to kick the habit, new research suggests.

This approach has been successful in other countries and should be tried and studied in the United States, according to a study by the RAND Corporation, a nonprofit global research organization.

"Given the increasing number of deaths associated with fentanyl and successful use of heroin-assisted treatment abroad, the U.S. should pilot and study this approach in some cities," said study leader Beau Kilmer, co-director of the RAND Drug Policy Research Center.

"This is not a silver bullet or first-line treatment. But there is evidence that it helps stabilize the lives of some people who use heroin," Kilmer said in a RAND news release.

Specifically, these are people unable to quit heroin after trying traditional treatments such as methadone and buprenorphine, the researchers said.

To assess the effectiveness of heroin-assisted treatment, the researchers examined evidence from Canada, the Netherlands, Switzerland and the United Kingdom.

They found that prescribing heroin injections under medical observation -- with optional take-home methadone -- has advantages over methadone alone for addicts who have repeatedly tried traditional addiction treatments without success.

While the top priority should be increasing access to traditional treatments, the severity of the U.S. opioid crisis requires other approaches to saving lives, according to the study authors.

Opioid addiction affects about 9 out of every 1,000 Americans and opioid overdose deaths have quadrupled over the past 15 years. More than 49,000 people died from opioid overdoses in the United States in 2017, the researchers said in background notes.

Kilmer and his colleagues also assessed safe injection sites in those other countries -- places where addicts can inject drugs purchased on the street. These drug consumption sites can reduce the risk of a fatal overdose, infectious disease transmission and other risks associated with unhygienic drug use, they concluded.

Many such programs have operated for 15 to 30 years and have survived multiple changes in local and national governments, the study team said.

"Persistence does not imply effectiveness, but it seems unlikely that supervised consumption sites -- which were initially controversial in many places -- would have such longevity if they had serious adverse consequences for their clients or communities," Kilmer said.

More information

The U.S. National Institute on Drug Abuse has more about heroin.




328 W. Claiborne St.
P.O. Box 964
Monroeville,
Alabama 36460
Tel: (251)575-4203
Fax:(251)575-9459


powered by centersite dot net